Assertio Holdings, Inc. (ASRT)
USD 0.65
(-0.06%)
USD 0.65
(-0.06%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -331.94 Million USD | -402.8% |
| 2022 | 109.62 Million USD | 8657.77% |
| 2021 | -1.28 Million USD | 95.45% |
| 2020 | -28.14 Million USD | 87.04% |
| 2019 | -217.2 Million USD | -688.49% |
| 2018 | 36.9 Million USD | 136.01% |
| 2017 | -102.49 Million USD | -15.53% |
| 2016 | -88.72 Million USD | -17.14% |
| 2015 | -75.73 Million USD | -157.48% |
| 2014 | 131.76 Million USD | 204.21% |
| 2013 | 43.31 Million USD | 245.44% |
| 2012 | -29.78 Million USD | -142.11% |
| 2011 | 70.72 Million USD | 1715.35% |
| 2010 | 3.89 Million USD | 117.7% |
| 2009 | -22 Million USD | -43.82% |
| 2008 | -15.3 Million USD | -131.09% |
| 2007 | 49.21 Million USD | 224.1% |
| 2006 | -39.65 Million USD | -62.09% |
| 2005 | -24.46 Million USD | 8.95% |
| 2004 | -26.87 Million USD | 10.47% |
| 2003 | -30.01 Million USD | -122.42% |
| 2002 | -13.49 Million USD | 23.33% |
| 2001 | -17.6 Million USD | -81.39% |
| 2000 | -9.7 Million USD | 43.62% |
| 1999 | -17.2 Million USD | -514.6% |
| 1998 | -2.8 Million USD | -133.33% |
| 1997 | -1.2 Million USD | -140.0% |
| 1996 | -500 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -4.51 Million USD | 92.14% |
| 2024 Q2 | -3.67 Million USD | 18.54% |
| 2023 FY | -331.94 Million USD | -402.8% |
| 2023 Q2 | 8.47 Million USD | 343.11% |
| 2023 Q3 | -279.54 Million USD | -3400.4% |
| 2023 Q4 | -57.38 Million USD | 79.47% |
| 2023 Q1 | -3.48 Million USD | -103.93% |
| 2022 FY | 109.62 Million USD | 8657.77% |
| 2022 Q4 | 88.55 Million USD | 2021.54% |
| 2022 Q1 | 9.06 Million USD | 96.79% |
| 2022 Q2 | 7.83 Million USD | -13.57% |
| 2022 Q3 | 4.17 Million USD | -46.72% |
| 2021 Q2 | -14.16 Million USD | -411.82% |
| 2021 Q3 | 3.73 Million USD | 126.37% |
| 2021 Q4 | 4.6 Million USD | 23.25% |
| 2021 FY | -1.28 Million USD | 95.45% |
| 2021 Q1 | 4.54 Million USD | 118.66% |
| 2020 Q2 | -34.49 Million USD | -183.67% |
| 2020 Q3 | -10.52 Million USD | 69.5% |
| 2020 FY | -28.14 Million USD | 87.04% |
| 2020 Q1 | 41.23 Million USD | 121.4% |
| 2020 Q4 | -24.35 Million USD | -131.45% |
| 2019 Q4 | -192.62 Million USD | -5882.83% |
| 2019 Q2 | -13.6 Million USD | 4.87% |
| 2019 Q3 | 3.33 Million USD | 124.48% |
| 2019 FY | -217.2 Million USD | -688.49% |
| 2019 Q1 | -14.3 Million USD | 40.75% |
| 2018 Q3 | 53.61 Million USD | 354.7% |
| 2018 FY | 36.9 Million USD | 136.01% |
| 2018 Q1 | 33.82 Million USD | 202.17% |
| 2018 Q2 | -21.04 Million USD | -162.23% |
| 2018 Q4 | -24.13 Million USD | -145.03% |
| 2017 Q4 | -33.1 Million USD | -107.0% |
| 2017 FY | -102.49 Million USD | -15.53% |
| 2017 Q1 | -26.74 Million USD | 39.73% |
| 2017 Q2 | -26.65 Million USD | 0.31% |
| 2017 Q3 | -15.99 Million USD | 40.01% |
| 2016 FY | -88.72 Million USD | -17.14% |
| 2016 Q4 | -44.36 Million USD | -244.1% |
| 2016 Q3 | -12.89 Million USD | -22.32% |
| 2016 Q2 | -10.54 Million USD | 49.61% |
| 2016 Q1 | -20.91 Million USD | 31.79% |
| 2015 Q2 | -21.65 Million USD | -86.13% |
| 2015 Q1 | -11.63 Million USD | -112.29% |
| 2015 Q3 | -11.78 Million USD | 45.57% |
| 2015 Q4 | -30.66 Million USD | -160.22% |
| 2015 FY | -75.73 Million USD | -157.48% |
| 2014 FY | 131.76 Million USD | 204.21% |
| 2014 Q4 | 94.62 Million USD | 1366.11% |
| 2014 Q3 | 6.45 Million USD | -49.36% |
| 2014 Q2 | 12.74 Million USD | -28.95% |
| 2014 Q1 | 17.93 Million USD | -57.08% |
| 2013 FY | 43.31 Million USD | 245.44% |
| 2013 Q1 | -5.48 Million USD | -47.95% |
| 2013 Q3 | 6.51 Million USD | 1262.76% |
| 2013 Q2 | 478 Thousand USD | 108.72% |
| 2013 Q4 | 41.8 Million USD | 541.71% |
| 2012 Q3 | -1.49 Million USD | 90.53% |
| 2012 Q1 | -8.8 Million USD | 36.37% |
| 2012 FY | -29.78 Million USD | -142.11% |
| 2012 Q4 | -3.7 Million USD | -147.76% |
| 2012 Q2 | -15.78 Million USD | -79.24% |
| 2011 Q1 | 98.81 Million USD | 5685.54% |
| 2011 Q2 | -5.67 Million USD | -105.75% |
| 2011 Q4 | -13.83 Million USD | -61.35% |
| 2011 FY | 70.72 Million USD | 1715.35% |
| 2011 Q3 | -8.57 Million USD | -51.01% |
| 2010 Q3 | 1.89 Million USD | -54.17% |
| 2010 Q1 | -3.82 Million USD | -5.98% |
| 2010 Q2 | 4.12 Million USD | 207.81% |
| 2010 Q4 | 1.7 Million USD | -9.68% |
| 2010 FY | 3.89 Million USD | 117.7% |
| 2009 FY | -22 Million USD | -43.82% |
| 2009 Q1 | -10.15 Million USD | 9.56% |
| 2009 Q2 | -9.61 Million USD | 5.32% |
| 2009 Q3 | 1.37 Million USD | 114.28% |
| 2009 Q4 | -3.61 Million USD | -363.0% |
| 2008 Q4 | -11.22 Million USD | -4043.54% |
| 2008 Q3 | -271 Thousand USD | -108.21% |
| 2008 Q2 | 3.3 Million USD | 145.32% |
| 2008 Q1 | -7.28 Million USD | -129.66% |
| 2008 FY | -15.3 Million USD | -131.09% |
| 2007 Q4 | 24.55 Million USD | -44.38% |
| 2007 Q1 | -10.86 Million USD | -16.14% |
| 2007 FY | 49.21 Million USD | 224.1% |
| 2007 Q2 | -8.96 Million USD | 17.54% |
| 2007 Q3 | 44.14 Million USD | 592.69% |
| 2006 FY | -39.65 Million USD | -62.09% |
| 2006 Q3 | -12.63 Million USD | -27.38% |
| 2006 Q2 | -9.91 Million USD | -27.92% |
| 2006 Q1 | -7.75 Million USD | -98.13% |
| 2006 Q4 | -9.35 Million USD | 25.94% |
| 2005 FY | -24.46 Million USD | 8.95% |
| 2005 Q1 | -6.77 Million USD | -15.63% |
| 2005 Q2 | -6.81 Million USD | -0.54% |
| 2005 Q3 | -6.96 Million USD | -2.27% |
| 2005 Q4 | -3.91 Million USD | 43.84% |
| 2004 Q4 | -5.85 Million USD | 12.58% |
| 2004 Q1 | -6.68 Million USD | 29.73% |
| 2004 FY | -26.87 Million USD | 10.47% |
| 2004 Q2 | -7.63 Million USD | -14.21% |
| 2004 Q3 | -6.7 Million USD | 12.15% |
| 2003 Q3 | -7.03 Million USD | 1.83% |
| 2003 Q4 | -9.5 Million USD | -35.13% |
| 2003 Q2 | -7.16 Million USD | -13.73% |
| 2003 Q1 | -6.3 Million USD | -179.75% |
| 2003 FY | -30.01 Million USD | -122.42% |
| 2002 Q4 | 7.9 Million USD | 189.36% |
| 2002 FY | -13.49 Million USD | 23.33% |
| 2002 Q3 | -8.84 Million USD | -26.33% |
| 2002 Q2 | -7 Million USD | -26.04% |
| 2002 Q1 | -5.55 Million USD | -13.64% |
| 2001 Q3 | -4.58 Million USD | 6.98% |
| 2001 Q1 | -3.18 Million USD | 8.79% |
| 2001 FY | -17.6 Million USD | -81.39% |
| 2001 Q2 | -4.93 Million USD | -54.67% |
| 2001 Q4 | -4.88 Million USD | -6.49% |
| 2000 FY | -9.7 Million USD | 43.62% |
| 2000 Q4 | -3.49 Million USD | -47.02% |
| 2000 Q3 | -2.37 Million USD | -9.16% |
| 2000 Q1 | -1.64 Million USD | 87.89% |
| 2000 Q2 | -2.17 Million USD | -32.28% |
| 1999 FY | -17.2 Million USD | -514.6% |
| 1999 Q4 | -13.6 Million USD | -807.25% |
| 1999 Q2 | -1.2 Million USD | -20.0% |
| 1999 Q1 | -1 Million USD | 9.09% |
| 1999 Q3 | -1.5 Million USD | -25.0% |
| 1998 FY | -2.8 Million USD | -133.33% |
| 1998 Q2 | -600 Thousand USD | -20.0% |
| 1998 Q3 | -600 Thousand USD | 0.0% |
| 1998 Q4 | -1.1 Million USD | -83.33% |
| 1998 Q1 | -500 Thousand USD | -25.0% |
| 1997 Q3 | -400 Thousand USD | -100.0% |
| 1997 Q2 | -200 Thousand USD | 0.0% |
| 1997 Q4 | -400 Thousand USD | 0.0% |
| 1997 FY | -1.2 Million USD | -140.0% |
| 1997 Q1 | -200 Thousand USD | 0.0% |
| 1996 FY | -500 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -209.24 Million USD | -58.636% |
| Theratechnologies Inc. | -23.95 Million USD | -1285.574% |
| Safety Shot Inc | -15.08 Million USD | -2100.763% |
| Cosmos Health Inc. | -18.54 Million USD | -1690.154% |
| Cronos Group Inc. | -73.96 Million USD | -348.795% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 66.88% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | -686.611% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 6812.679% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -5285.992% |
| ProPhase Labs, Inc. | -16.78 Million USD | -1877.964% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -6765.398% |
| Dynavax Technologies Corporation | -6.38 Million USD | -5095.524% |
| Radius Health, Inc. | -25.79 Million USD | -1187.046% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -10612.88% |
| Alvotech | -551.73 Million USD | 39.836% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -7266.595% |
| Alpha Teknova, Inc. | -36.78 Million USD | -802.507% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | -137.655% |
| SCYNEXIS, Inc. | 67.04 Million USD | 595.133% |
| Harrow Health, Inc. | -24.41 Million USD | -1259.805% |
| Biofrontera Inc. | -20.13 Million USD | -1548.91% |
| DURECT Corporation | -27.62 Million USD | -1101.643% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 25323.556% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 1867.623% |
| OptiNose, Inc. | -35.48 Million USD | -835.496% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 1487.949% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -4117.814% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -5186.273% |
| SIGA Technologies, Inc. | 68.06 Million USD | 587.656% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 2863.19% |
| Shineco, Inc. | -22.44 Million USD | -1378.648% |
| Phibro Animal Health Corporation | 2.41 Million USD | 13839.321% |
| Procaps Group S.A. | 42.54 Million USD | 880.306% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -3129.636% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -7616.285% |
| Viatris Inc. | 54.7 Million USD | 706.841% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -7266.595% |
| Rockwell Medical, Inc. | -8.43 Million USD | -3833.428% |
| Incannex Healthcare Limited | -18.45 Million USD | -1698.266% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -1995.064% |
| Tilray Brands, Inc. | -244.98 Million USD | -35.497% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 789.32% |
| PetIQ, Inc. | 2.13 Million USD | 15676.818% |
| Silver Spike Investment Corp. | 7.34 Million USD | 4622.304% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 232.936% |
| Journey Medical Corporation | -3.85 Million USD | -8515.157% |
| Alimera Sciences, Inc. | -20.13 Million USD | -1548.828% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -3966.328% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -4934.976% |
| Embecta Corp. | 70.4 Million USD | 571.509% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1554.968% |
| Procaps Group, S.A. | 42.54 Million USD | 880.306% |
| PainReform Ltd. | -9.34 Million USD | -3452.461% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | -107.106% |
| Hempacco Co., Inc. | -13.12 Million USD | -2428.874% |
| Talphera, Inc. | -18.39 Million USD | -1704.327% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 891.186% |
| Alvotech | -551.73 Million USD | 39.836% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 201.617% |
| Kamada Ltd. | 8.28 Million USD | 4107.026% |
| Indivior PLC | 2 Million USD | 16697.1% |
| Currenc Group, Inc. | -15.3 Million USD | -2068.627% |
| Evoke Pharma, Inc. | -7.79 Million USD | -4159.875% |
| Flora Growth Corp. | -57.03 Million USD | -481.987% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1554.968% |
| Evolus, Inc. | -61.68 Million USD | -438.124% |
| HUTCHMED (China) Limited | 100.78 Million USD | 429.373% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 341.333% |
| Akanda Corp. | -32.27 Million USD | -928.478% |